|
Volumn 46, Issue 1, 2006, Pages 180-181
|
Amphetamine, migraine, and brain noradrenergic activation: Contradictions in headache research [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR;
AMITRIPTYLINE;
BETA ADRENERGIC RECEPTOR;
CAFFEINE;
DEXAMPHETAMINE;
IBUPROFEN;
NORADRENALIN;
PHENETHYLAMINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ANALGESIC ACTIVITY;
CHRONIC TENSION HEADACHE;
CLINICAL FEATURE;
HEADACHE;
HUMAN;
LETTER;
MIGRAINE;
NERVE CELL EXCITABILITY;
NEUROTOXICITY;
NORADRENALIN BRAIN LEVEL;
NORADRENALIN RELEASE;
NORADRENERGIC SYSTEM;
PATHOGENESIS;
PRIORITY JOURNAL;
SEIZURE;
SYMPATHETIC NERVE;
TREATMENT CONTRAINDICATION;
BRAIN;
BRAIN CHEMISTRY;
CAFFEINE;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CROSS-OVER STUDIES;
DEXTROAMPHETAMINE;
HUMANS;
MIGRAINE DISORDERS;
NOREPINEPHRINE;
PILOT PROJECTS;
TENSION-TYPE HEADACHE;
|
EID: 33645101197
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2006.00321_3.x Document Type: Letter |
Times cited : (1)
|
References (9)
|